Breast, Lung Cancer Genetics Highlight Mutations Linked to Drug Response, Prognosis

NEW YORK (GenomeWeb) – A pair of new studies are continuing to spell out the somatic mutations that can provide clues to prognoses and/or drug response in specific forms of breast or lung cancer. 

To read the full story….

…and receive Daily News bulletins.

Already have an account?

Source link

Leave a Reply

Your email address will not be published.